Loading…

Usefulness of interventional embolization of the middle meningeal artery for recurrent chronic subdural hematoma: Five cases and a review of the literature

PurposeAlthough several strategies against recurrent chronic subdural hematoma (CSDH) have been proposed, no consensus has been established. Recently, middle meningeal artery (MMA) embolization has been proposed as radical treatment for recurrent CSDH. We wanted to estimate the usefulness of MMA emb...

Full description

Saved in:
Bibliographic Details
Published in:Interventional neuroradiology 2015-06, Vol.21 (3), p.366-371
Main Authors: Tempaku, Akira, Yamauchi, Shigeru, Ikeda, Hidetoshi, Tsubota, Nobuyuki, Furukawa, Hironori, Maeda, Daisuke, Kondo, Kimito, Nishio, Akimasa
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:PurposeAlthough several strategies against recurrent chronic subdural hematoma (CSDH) have been proposed, no consensus has been established. Recently, middle meningeal artery (MMA) embolization has been proposed as radical treatment for recurrent CSDH. We wanted to estimate the usefulness of MMA embolization for recurrent CSDH. MethodsFrom February 2012 to June 2013, 110 patients with CSDH underwent single burr-hole surgery with irrigation and drainage. Among these patients, 13 showed recurrent hematoma formation and were retreated surgically. Furthermore, repeated recurrence of CSDH was observed in six patients. Five of these six patients underwent middle meningeal artery (MMA) embolization with polyvinyl alcohol particles. All five patients with interventional treatment were observed for four to 60 weeks. ResultsNo more recurrence of CSDH was observed in any of the patients. During the follow-up period, no patients suffered from any side effects or complications from the interventional treatment. ConclusionMMA embolization with careful attention paid to the procedure might be a treatment of choice for recurrent CSDH.
ISSN:1591-0199
2385-2011
DOI:10.1177/1591019915583224